Drewes; Gerard

Patent Applications and Registrations

Patent applications and USPTO patent grants for Drewes; Gerard.The latest application filed is for "in vivo method for the evaluation of a compound-target interaction".

Company Profile

0.4.24

Drewes; Gerard - Heidelberg DE
Drewes; Gerard - Heidelburg DE
Drewes; Gerard - Hamburg DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods for the Identification of Methyltransferase Interacting Molecules and for the Purification of Methyltransferase Proteins App 20130210664 - Harrison; John ; et al.	2013-08-15
In Vivo Method For The Evaluation Of A Compound-target Interaction App 20130210030 - Drewes; Gerard ; et al.	2013-08-15
Methods For The Identification And Characterization Of Hdac Interacting Compounds App 20130071854 - Drewes; Gerard ; et al.	2013-03-21
Methods For The Identification Of Zap-70 Interacting Molecules And For The Purification Of Zap-70 App 20120178180 - Kruse; Ulrich ; et al.	2012-07-12
Methods for the identification of LRRK2 interacting molecules Grant 8,163,511 - Drewes , et al. April 24, 2	2012-04-24
Sulfonamides As Zap-70 Inhibitors App 20110098288 - Major; Jeremy ; et al.	2011-04-28
Methods For The Identification Of Parp Interacting Molecules And For Purification Of Parp Proteins App 20110070595 - Drewes; Gerard ; et al.	2011-03-24
Sulfamides As Zap-70 Inhibitors App 20110028405 - Harrison; Richard John ; et al.	2011-02-03
Process for the identification of novel enzyme interacting compounds App 20090238808 - Drewes; Gerard ; et al.	2009-09-24
Methods For The Identification Of Lrrk2 Interacting Molecules And For The Purification Of Lrrk2 App 20090220992 - Drewes; Gerard ; et al.	2009-09-03
Novel Tools for the Diagnosis and Treatment of Alzheimer's Disease App 20090162336 - Mandelkow; Eva-Marie ; et al.	2009-06-25
Treatment of neurodegenerative diseases by the use of scd4 inhibitors App 20090098105 - Hopf; Carsten ; et al.	2009-04-16
Protein kinase (NPK-110) Grant 7,485,712 - Mandelkow , et al. February 3, 2	2009-02-03
Use of Eph Receptor Inhibitors for the Treatment of Neurodegenerative Diseases App 20080213250 - Hopf; Carsten ; et al.	2008-09-04
Tools for the diagnosis and treatment of Alzheimer's disease Grant 7,408,027 - Mandelkow , et al. August 5, 2	2008-08-05
Treatment Of Neurodegenerative Diseases By The Use Of Laptm4a App 20080038249 - Hopf; Carsten ; et al.	2008-02-14
Treatment of Neurodegenerative Diseases by the Use of Gpr49 App 20080025969 - Hopf; Carsten ; et al.	2008-01-31
Treatment of Neurodegenerative Diseases by the Use of Degs Inhibitors App 20070298029 - Hopf; Carsten ; et al.	2007-12-27
Treatment Of Neurodegenerative Diseases By The Use Of Atp7a App 20070280927 - Hopf; Carsten ; et al.	2007-12-06
Treatment of neurodegenerative diseases by the use of laptm4b App 20070161554 - Hopf; Carsten ; et al.	2007-07-12
Tools for the diagnosis and treatment of Alzheimer's disease Grant 7,176,290 - Mandelkow , et al. February 13, 2	2007-02-13
Protein complexes of the tip60 transcriptional activator protein App 20060264610 - Merino; Alejandro ; et al.	2006-11-23
Novel protein kinase (NPK-110) App 20040038361 - Mandelkow, Eckhard ; et al.	2004-02-26
Protein Kinase Npk-110 App 20030104516 - MANDELKOW, ECKHARD ; et al.	2003-06-05
Novel tools for the diagnosis and treatment of Alzheimer's disease App 20020188106 - Mandelkow, Eva-Marie ; et al.	2002-12-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.